Category Archives: Medical Devices
Cardiovascular Systems, Inc. Announces First In-Human Experience With Company’s Propel™ Percutaneous Ventricular Assist Device
Below, we are re-publishing with permission the press-release issued by Cardiovascular Systems, Inc. on March 16, 2022 ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with … Continue reading
Maxwell Biomedical Initiates First-in-Human Trial to Assess the Safety and Efficacy of а Novel Pacing Intervention in Patients with Atrial Fibrillation
Spatial Resynchronization Therapy™ (SR ™Т) Successfully Terminated Atrial Fibrillation Below, we are re-publishing with permission the press-release issued by Maxwell Biomedical on July 14, 2022 SAN DIEGO, Calif., July 14, 2022. Maxwell Biomedical announced today that it has initiated its … Continue reading
Clinical Accelerator announces collaboration with Argá Medtech – developers of a novel cardiac ablation system for the treatment of cardiac arrhythmias
Clinical Accelerator, a full-service, medical device focused contract research organization, is excited to announce a new collaboration with Argá Medtech, on their feasibility study exploring the safety and efficacy of Argá’s non-thermal cardiac ablation system targeting Atrial Fibrillation (AF) The … Continue reading
Clinical Accelerator announces collaboration with CryoTherapuetics – a medical device company focused on treating coronary artery disease
Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a new partnership with CryoTherapeutics – an early-stage European medical device company which has developed a novel cryoenergy therapy for the treatment of inflamed atherosclerotic plaque, … Continue reading
Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial
Below, we are re-publishing with permission the press-release issued by Axon Therapies on May 23, 2022 Late-breaking results presented at the European Society of Cardiology’s Heart Failure Association annual conference and simultaneously published online in the European Journal of Heart … Continue reading
Miracor Medical starts 2nd randomized study, targeting expanded indications. 300 patients have been treated with PiCSO®
Below, we are re-publishing with permission the press-release issued by Miracor Medical on March 29, 2022 AWANS, Belgium, March 29, 2022 /PRNewswire/ — Miracor Medical SA (Miracor Medical) today announced the first patient enrolled in the PICSO-AMI-V study to evaluate the benefits … Continue reading
Clinical Accelerator announces collaboration with Deerfield Catalyst, a medtech incubator committed to developing transformational solutions to improve patient outcomes and streamline care
Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a collaboration with Deerfield Catalyst. The company combines the resources of two established health pioneers: Coridea, a New-York based, premier Medical Device Incubator; and Deerfield, an … Continue reading
ANTERIS REPORTS SUCCESSFUL INTERIM RESULTS FOR THE FIRST-IN-HUMAN TRIAL FOR DurAVR
Below, we are re-publishing with permission the press-release issued by Anteris Technologies Ltd on January 24, 2022 Brisbane, Australia and Minneapolis, USA, Anteris Technologies Ltd (ASX: AVR) reports the first-in-human DurAVR™ THV study met or exceeded its interim study objectives.At … Continue reading
Sequana Medical announces positive interim results of SAHARA DESERT, the alfapump DSR® study in heart failure patients with persistent congestion
Below, we are re-publishing with permission the press-release issued by Sequana Medical NV on December 07, 2021 Interim data from six patients indicate that alfapump DSR therapy can: safely, effectively and rapidly eliminate persistent congestion and restore euvolemia in diuretic-resistant … Continue reading
Early Feasibility Study Demonstrates Successful Use of Abiomed’s preCARDIA Technology
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces the successful results of the first-in-human early feasibility study of the preCARDIA system. The preCARDIA system is designed to improve decongestion in acutely decompensated heart failure (ADHF) patients by intermittently occluding the superior vena cava. … Continue reading
clinicalaccelerator.com 
You must be logged in to post a comment.